Healthcare provider profile · identity verified

Michael A. Barkasy, M.D.

Family Practice · WEST GROVE, PA · NPI 1235199589

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	461	128
Amlodipine Besylate	Amlodipine Besylate	352	99
Levothyroxine Sodium	Levothyroxine Sodium	238	63
Lisinopril	Lisinopril	233	70
Simvastatin	Simvastatin	190	50
Metoprolol Succinate	Metoprolol Succinate	182	49
Metformin Hcl	Metformin Hcl	161	45
Hydrochlorothiazide	Hydrochlorothiazide	142	39
Omeprazole	Omeprazole	139	41
Gabapentin	Gabapentin	122	27
Losartan Potassium	Losartan Potassium	116	36
Sertraline Hcl	Sertraline Hcl	108	33
Tamsulosin Hcl	Tamsulosin Hcl	105	31
Rosuvastatin Calcium	Rosuvastatin Calcium	104	32
Tramadol Hcl	Tramadol Hcl	104	20
Pantoprazole Sodium	Pantoprazole Sodium	102	32
Zolpidem Tartrate	Zolpidem Tartrate	96	19
Valsartan	Valsartan	90	28
Alprazolam	Alprazolam	81	20
Lorazepam	Lorazepam	80	15
Albuterol Sulfate Hfa	Albuterol Sulfate	79	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	78	24
Meloxicam	Meloxicam	78	29
Escitalopram Oxalate	Escitalopram Oxalate	74	16
Furosemide	Furosemide	68	25
Synthroid	Levothyroxine Sodium	68	17
Eliquis	Apixaban	66	17
Carvedilol	Carvedilol	61	17
Trazodone Hcl	Trazodone Hcl	58	21
Ozempic	Semaglutide	54	12
Fluticasone Propionate	Fluticasone Propionate	53	16
Duloxetine Hcl	Duloxetine Hcl	51	16
Bupropion Xl	Bupropion Hcl	49	16
Clonazepam	Clonazepam	48	suppressed
Pravastatin Sodium	Pravastatin Sodium	48	18
Baclofen	Baclofen	43	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	43	13
Allopurinol	Allopurinol	42	13
Doxycycline Monohydrate	Doxycycline Monohydrate	40	30
Fluconazole	Fluconazole	38	suppressed
Prednisone	Prednisone	38	19
Atenolol	Atenolol	37	11
Metformin Hcl Er	Metformin Hcl	37	11
Diazepam	Diazepam	36	suppressed
Januvia	Sitagliptin Phosphate	36	suppressed
Valacyclovir	Valacyclovir Hcl	36	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	32
Montelukast Sodium	Montelukast Sodium	34	12
Olmesartan Medoxomil	Olmesartan Medoxomil	30	suppressed
Lansoprazole	Lansoprazole	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Glipizide Er	Glipizide	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	27	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Famotidine	Famotidine	24	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Glimepiride	Glimepiride	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Potassium Chloride	Potassium Chloride	24	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Alendronate Sodium	Alendronate Sodium	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Azithromycin	Azithromycin	20	17
Spironolactone	Spironolactone	20	suppressed
Testosterone	Testosterone	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Glipizide	Glipizide	18	suppressed
Nabumetone	Nabumetone	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	17
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Carisoprodol	Carisoprodol	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	14
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Methylprednisolone	Methylprednisolone	15	13
Myrbetriq	Mirabegron	15	suppressed
Ramipril	Ramipril	15	suppressed
Topiramate	Topiramate	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Fentanyl	Fentanyl	14	suppressed
Levemir Flexpen	Insulin Detemir	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	12	suppressed
Temazepam	Temazepam	12	suppressed
Zaleplon	Zaleplon	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Cefuroxime	Cefuroxime Axetil	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Sucralfate	Sucralfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error